Navigation Links
DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
Date:3/15/2013

Wynnewood, PA (PRWEB) March 15, 2013

CD Diagnostics announced today that they will be featured in an upcoming episode of Health Heroes.

Located in Wynnewood, PA, CD Diagnostics is a leader in joint fluid analysis. The company’s scientific founder, Carl Deirmengian, MD, discovered the existence of unique genetic signatures for joint disease and infection, as indicated by the presence of various biomarkers in synovial (joint) fluid. By identifying and measuring these unique biomarkers, CD Diagnostics is able to develop a series of new products to diagnose joint disease with greater accuracy and speed than other tests currently available. The company’s first joint infection test, marketed as Synovasure™, was released as a laboratory developed test in November 2012 and continues to receive tremendous positive feedback from the orthopaedic community. A point of care device that will diagnose joint infection at the bedside is currently being developed, and the company plans to release this test in Europe later this year.

Matt Monaghan, Global Vice President of Zimmer Hips, commented that, "The early detection and treatment of infection is critical to successful clinical outcomes. We believe Synovasure™ will enable surgeons to quickly and accurately identify patients presenting with infection through a simple, streamlined process."

This particular episode of Health Heroes will educate our viewers about the impact of CD Diagnostics' game changing technology for the orthopaedic community. The company’s pipeline of tests will be the first simple, standardized, analytical devices available for joint fluid analysis. The Health Heroes feature will explain CD Diagnostics’ biomarker screening program, patented technology, and its core strengths in immunoassay development and manufacturing. Through the combination of its CLIA laboratory, Citrano Medical Laboratories, and its strength in immunoassay development, CD Diagnostics is able to develop diagnostic tests for a broad range of joint diseases including infection, rheumatoid arthritis, osteoarthritis, and companion diagnostics in a simple, rapid, and accurate format.

Testing services for Synovasure™ LDT, the company’s joint infection test, are provided through CD Diagnostics’ CLIA lab in Towson, Maryland. Results are turned around to physicians within 24hrs.

Richard Birkmeyer, CEO of CD Diagnostics stated, “We are very excited about our feature on Health Heroes. We believe that our breakthrough technology will have a tremendous impact on the orthopaedic community and are pleased to shed light on joint infection, a serious condition that negatively affects joint replacement patients worldwide.”

“When discussing technology, the true marvels today are happening behind closed doors,” said Michele Nehls, producer for the Health Heroes series. “I’m proud to be able to bring an inside perspective to the Health Heroes audience.”

About CD Diagnostics:
CD Diagnostics is a leader in joint fluid analysis focused on developing novel diagnostic tests for joint disease. The Company aims to improve patient outcomes through innovative technologies that provide more accurate and rapid diagnosis for joint pain and infection. As part of its commitment to joint fluid research, CD Diagnostics is creating a repository of joint fluid samples from a global network of physicians to facilitate biomarker screening services for synovial and spinal fluids. Combining biomarker identification with patented technology and expertise in immunoassay development and manufacturing, CD Diagnostics is developing a range of products that address challenging diagnostic determinations in joint health and therapeutic outcomes.

For more information, visit: http://www.cddiagnostics.com or call (484) 476-4800.

About Health Heroes:
Health Heroes is a powerful TV series dedicated to defining and exploring today’s latest medical advances in all areas of health and wellness. Written with both the industry professional and television audience in mind, Health Heroes educates, entertains and enlightens the lives of our viewers.

For more information visit: http://www.dmgproductions.org or call (866) 496-4065.

Media Contact:
Michele Nehls, Executive Producer - Health Heroes
DMG Productions
(866) 496-4065 x 822

Read the full story at http://www.prweb.com/releases/2013/3/prweb10524109.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Health Heroes and DMG Productions Proudly Announce Airing of New Episodes
2. Waterfront Properties Proud To Have Prestigious Max Planck Society in its Back Yard
3. The Scientist Proudly Announces the Top 10 Innovations of 2012
4. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
5. Verenium Announces Preliminary Financial Results For Fiscal 2012
6. Probiotic Action Announces Probiotics Lead the Digestive Health Market
7. Annual Conference about Technology Solutions for People with Disabilities Announces Program
8. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
9. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
10. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
11. EAG Announces General Manager of Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016   ... a biopharmaceutical company focused on the development and commercialization of ... the 18 th Annual BIO CEO & Investor ... EST in New York, NY . ... provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... 11, 2016 Synaptics Incorporated (NASDAQ: SYNA ... announced that its ClearPad ® TouchView ™ ... two separate categories in the 8 th Annual ... Technology Breakthrough. The Synaptics ® TDDI solution enables ... chain, thinner devices, brighter displays and borderless designs. ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):